Sowell Financial Services LLC Cellectis S.A. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$14.36 - $20.93 $5,327 - $7,765	-371 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$18.19 - $33.25 $3,783 - $6,916	-208 Reduced 35.92%	371 $6,000
Q4 2020 Jan 13, 2021	BUY	$15.87 - $31.64 $4,745 - $9,460	299 Added 106.79%	579 $16,000
Q2 2020 Aug 13, 2020	SELL	$8.21 - $21.02 $7,635 - $19,548	-930 Reduced 76.86%	280 $5,000
Q1 2020 May 12, 2020	BUY	$7.81 - $18.82 $9,450 - $22,772	1,210 New	1,210 $11,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.